SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : The Microcap Kitchen: Stocks 5¢ to $5

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Coz who started this subject4/22/2004 2:21:52 PM
From: GARY P GROBBEL   of 120409
 
CMPD .24/.29 vol 80,000...i have been waiting until they got their first sale into China...China has a very big osteoporosis problem for whatever reason...it is a major concern over there...maybe it is diet...17m shares out:

(COMTEX) B: CompuMed Ships First DICOM OsteoGram(R) System Chinese Distrib
tor Makes Initial Placement ( PRNewswire-FirstCall )
B: CompuMed Ships First DICOM OsteoGram(R) System Chinese Distributor Makes Init
al Placement ( PRNewswire-FirstCall )

LOS ANGELES, Apr 22, 2004 /PRNewswire-FirstCall via COMTEX/ -- CompuMed, Inc.
(OTC Bulletin Board: CMPD) -- a medical informatics company serving the
healthcare community with diagnostic software solutions -- today announced that
it has begun shipping its DICOM OsteoGram system to international distributors.

The first system was shipped to Shanghai Sanchang Import & Export Co., LTD
(SSIE), CompuMed's DICOM distributor in the People's Republic of China.
Distribution by SSIE augments existing sales in China of the film-based
OsteoGram system by Golden Xi Tong in Tianjin.

SSIE sold its first DICOM OsteoGram system to a prominent hospital in Zhejiang
Province for integration with a major manufacturer's computed radiography (CR)
platform. Implementation is slated for early May and will represent CompuMed's
entry into the rapidly growing Chinese market for digital x-ray equipment. The
incidence of osteoporosis is high among the Chinese population, and the
government has identified the disease as one of its most important long-term
health concerns.

"We are delighted to announce delivery of our first DICOM OsteoGram system to
the burgeoning Chinese market," said Jerry McLaughlin, CompuMed's CEO. "We're
also encouraged by how the system will be implemented. The hospital's plan
reflects CompuMed's DICOM strategy, which stresses workstation consolidation.
The goal is to enable clinicians to utilize software applications integrated
into digital imaging platforms. This helps reduce the need for additional
dedicated equipment, redundant computer workstations and specially trained
staff."

The DICOM OsteoGram represents the latest advancement to CompuMed's popular
software-based imaging system for screening, diagnosing and monitoring
osteoporosis. It uses a digital image derived from filmless x-ray equipment to
enable clinicians to perform accurate and precise osteoporosis testing. DICOM
(Digital Communications and Imaging in Medicine) is the information standard
that allows the new generation of medical imaging equipment to interconnect.
DICOM-based systems, such as filmless x-ray platforms and PACS network servers,
have become a high growth segment of the medical imaging market.

About CompuMed:

Founded in 1973, CompuMed, Inc. (OTC Bulletin Board: CMPD) is a leading provider
of computer-aided telemedicine and diagnostics technology. The company's core
products are the OsteoGram and CardioGram systems. The OsteoGram, which is
cleared by the FDA for commercial use, is an accurate and precise technology for
low-cost osteoporosis testing. The CardioGram is a pioneering telemedicine
system that remotely interprets electrocardiograms on a real time basis. Used by
private practice, government and corporate healthcare providers nationwide, it
also has the capability to automatically provide an over-read (i.e., follow-up
review) by a cardiologist. CompuMed is headquartered in Los Angeles. Visit
CompuMed at www.compumed.net.

This news release contains forward-looking statements as defined by the Private
Securities Litigation Reform Act of 1995. Forward-looking statements include
statements concerning plans, objectives, goals, strategies, future events or
performance and underlying assumptions and other statements that are other than
statements of historical facts. These statements are subject to uncertainties
and risks including, but not limited to, product and service demand and
acceptance, changes in technology, ability to raise capital, the availability of
appropriate acquisition candidates and/or business partnerships, economic
conditions, the impact of competition and pricing, capacity and supply
constraints or difficulties, government regulation and other risks defined in
this document. All such forward-looking statements whether written or oral, and
whether made by or on behalf of the Company are expressly qualified by these
cautionary statements and any other cautionary statements which may accompany
the forward-looking statements. In addition, the Company disclaims any
obligation to update any forward-looking statements to reflect events or
circumstances after the date hereof.

SOURCE CompuMed, Inc.


CONTACT: Erik Deutsch of Tellem Worldwide, +1-310-479-6111, ext. 15,
edeutsch@tellem.com, for CompuMed, Inc.

URL: compumed.net
prnewswire.com

Copyright (C) 2004 PR Newswire. All rights reserved.

-0-


KEYWORD: California
INDUSTRY KEYWORD: HEA
MTC
CPR
STW
OTC
SUBJECT CODE: ASI
OTC

*** end of story ***
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext